Navigation Links
Express Plus Clinical Chemistry Analyzer

ProductsExpress Plus Clinical Chemistry Analyzer
Company Siemens Medical Solutions Diagnostics
Item Express Plus Clinical Chemistry Analyzer
  • Patient Oriented Random Access operation for maximum productivity and rapid response times
  • Bar-coded samples and reagents eliminate handling errors
  • A throughput of up to 180 tests per hour together with automatic on-board supplies management gives the operator over 1 hour of unattended operation
  • Multi-language screen options, printouts and keyboard characters ensure ease of use in all locations
  • Quality control program includes Levey Jennings graph and westgard rules
  • Data management capability with bi-directional interface, preprograms up to 48 tests and 360 patients
  • Simple user interface with menu-related functional keys for worklist entry via keyboard, bar-code sheet or download
  • Rapid response for STAT samples
  • One hour walk-away capability
  • 40 position serum cup tray or 20 position primary tube tray
  • Automatic predilution up to 1:100
  • Auto rerun of samples
  • Sample and reagent level detection.
Description The Express Plus clinical chemistry analyzer is a fully automated walk away system designed for maximum productivity, convenience and reliability.
Info Siemens Medical Solutions Diagnostics
Customer Service: 800-255-3232 or 914-631-8000
Web site:

Related medicine products :

1. Smith Expressor Hook
2. Opti-Free Express No Rub
3. Expressions Accents
4. Expressions colors
5. My Vision Express Software
6. ICP Express I.E.C.
7. ICP Express Monitoring System
8. Express Plus
9. Express Elyte Systems
10. Express Coronary Stent System
11. TAXUS Express2 Over-the-wire Paclitaxel-Eluting Coronary Stent System
... New Toyos Aqua-Chopper, Is Used In The ... With Aqualase Cataract Removal As Well As ... Blade Allows Easy Manipulation At The Incision Site ... Allows Safe Sweeping Of Nuclear Material Away ...
... The UAF LASIK ... And Two Pararadial Evenly ... Alignment Of The Lamellar ... Repositioning. The Pararadial Marks ...
... To Manually Dilate A Small Pupil With ... Maximizes Safety By Allowing The Iris Hooks ... To The Plane Of The Anterior Capsule, ... Tears. Pupil Stretching Is Also Maximized, With ...
... Unique Reversible Speculums Designed To Rest ... Flipping The Speculums Over, Allowing Eyelids ... Fissures To The Widest Possible Aperture.,Open ... Unobstructed Around-The-Clock Access To The Globe ...
Medicine Products:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition has announced ... Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday 2015, a ... including their ability to work and be productive, to do simple daily activities like ...
(Date:12/1/2015)... ... December 02, 2015 , ... ClinicoEconomics and Outcomes Research ... of treatment for osteoporosis ”. , As corresponding author Dr Ankita Modi says ... with osteoporosis. Based on a large US managed care database, women aged 55 ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an ... has filed a discrimination claim against the U.S. Department of Health and Human Services, ... Care Act (ACA) plans are breaking the clause in the law prohibiting the denial ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of the ... named by MedEsthetics magazine as the Best Single Physician Practice in the nation. Dr. ... elite aesthetic physicians honored by the industry publication. , Dr. Vitenas said he ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... FRANCISCO , Dec. 1, 2015  InCarda Therapeutics, ... development and commercialization of therapies for cardiovascular conditions via ... a subsidiary business in Australia . ... trial in Australia in the ... leading investigators and medical centers in Adelaide ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration ... to develop shared care plans that help patients ... care plans will be digitally enabled, incorporate care ... needs and desires. They will also allow all ... patient,s health journey is optimal. That is the ...
Breaking Medicine Technology: